NCT01624220 2023-12-05
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
M.D. Anderson Cancer Center
Phase NA Completed
M.D. Anderson Cancer Center
Oxford University Hospitals NHS Trust
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Lille Catholic University
M.D. Anderson Cancer Center
University of Pennsylvania
Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center